학술논문

Minimal residual disease undetectable by next-generation sequencing predicts improved outcome in CLL after chemoimmunotherapy
Document Type
Article
Source
In Blood 28 November 2019 134(22):1951-1959
Subject
Language
ISSN
0006-4971